| Financial Year |
March 31 2023 |
| Monetary Funds |
207,859,711.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,953,040.40 |
| Accounts Receivable |
295,103,809.68 |
| Advances to Suppliers |
34,789,100.10 |
| Other Receivables |
18,975,553.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
34,491.38 |
| Dividend Receivable |
-- |
| Inventories |
429,975,245.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,669,660.28 |
| Total Current Assets |
1,232,166,156.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,713,788.57 |
| Investment Properties |
-- |
| Fixed Assetes |
218,692,668.23 |
| Under-construction Projects |
247,787.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
294,100,008.29 |
| R&D expenses |
-- |
| Goodwill |
296,404,992.82 |
| Long-Term Deferred and Prepaid Expenses |
1,260,631.18 |
| Deferred Income Tax Assets |
69,638,226.35 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
951,627,476.83 |
| Total Assets |
2,183,793,633.13 |
| Short-Term Loans |
213,218,373.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
25,143,234.83 |
| Accounts Payable |
205,458,917.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,194,773.51 |
| Taxes Payable |
9,795,415.56 |
| Interest Payable |
114,848.38 |
| Dividend Payable |
-- |
| Other payables |
161,618,445.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,777,396.83 |
| Other Current Liabilities |
16,896,617.03 |
| Sub-Total of Current Liabilities |
959,376,278.36 |
| Long-term Loans |
8,725,883.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
135,083,410.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
11,850,478.43 |
| Deferred Income Tax Liabilities |
94,814,818.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
335,542,420.84 |
| Total Liabilities |
1,294,918,699.20 |
| Paid-In Capital(Or Share Stock) |
338,438,106.00 |
| Capital Surplus |
609,495,242.28 |
| Surplus Reserve |
40,365,901.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-121,896,711.10 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
888,874,933.93 |
| Owner's Equity（Stockholder's Equity） |
888,874,933.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,183,793,633.13 |
